To become a leading global biopharmaceutical company with integrated technology platforms addressing unmet medical needs in respiratory and lung diseases, by leveraging our first-in-class RSV drug and potentially best-in-class anti-fibrotic pipelines, as well as our pediatric drug development expertise.
We strive for scientific excellence and continuous innovation, with a focus on drug discovery and development for pediatric medicine, and for the treatment of respiratory and fibrotic diseases; We aspire to become a global leader in the research and development of innovative drugs in these specialty pharmaceutical fields; We endeavor to create a supportive and rewarding work environment for our employees, to generate favorable return for our investors and partners, and to return for the benefits of our community and society.
Ark's core values reflect our unwavering belief in achieving the vision to build a science-driven biopharmaceutical company: Integrity and Dedication, Professionalism and Motivation, Science and Innovation, Collaboration and Sharing.
  • Home
  • Tel
  • Top